Annual EBIT:
$20.84M+$120.79M(+120.85%)Summary
- As of today, FOLD annual earnings before interest & taxes is $20.84 million, with the most recent change of +$120.79 million (+120.85%) on December 31, 2024.
- During the last 3 years, FOLD annual EBIT has risen by +$229.93 million (+109.97%).
- FOLD annual EBIT is now at all-time high.
Performance
FOLD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$7.62M-$1.03M(-15.57%)Summary
- As of today, FOLD quarterly earnings before interest & taxes is -$7.62 million, with the most recent change of -$1.03 million (-15.57%) on June 30, 2025.
- Over the past year, FOLD quarterly EBIT has dropped by -$20.24 million (-160.35%).
- FOLD quarterly EBIT is now -123.02% below its all-time high of $33.08 million, reached on December 31, 2009.
Performance
FOLD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$25.16M-$20.24M(-44.57%)Summary
- As of today, FOLD TTM earnings before interest & taxes is $25.16 million, with the most recent change of -$20.24 million (-44.57%) on June 30, 2025.
- Over the past year, FOLD TTM EBIT has increased by +$74.24 million (+151.27%).
- FOLD TTM EBIT is now -44.57% below its all-time high of $45.40 million, reached on March 31, 2025.
Performance
FOLD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FOLD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +120.8% | -160.3% | +151.3% |
| 3Y3 Years | +110.0% | +85.6% | +110.5% |
| 5Y5 Years | +106.2% | +83.1% | +109.2% |
FOLD EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +110.0% | -138.3% | +87.1% | -44.6% | +111.5% |
| 5Y | 5-Year | at high | +106.2% | -138.3% | +89.6% | -44.6% | +109.2% |
| All-Time | All-Time | at high | +104.8% | -123.0% | +97.2% | -44.6% | +105.7% |
FOLD EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$7.62M(-15.6%) | $25.16M(-44.6%) |
| Mar 2025 | - | -$6.59M(-133.1%) | $45.40M(+117.8%) |
| Dec 2024 | $20.84M(+120.9%) | $19.89M(+2.1%) | $20.84M(+216.5%) |
| Sep 2024 | - | $19.48M(+54.3%) | -$17.88M(+63.6%) |
| Jun 2024 | - | $12.62M(+140.5%) | -$49.08M(+45.3%) |
| Mar 2024 | - | -$31.15M(-65.4%) | -$89.72M(+10.2%) |
| Dec 2023 | -$99.95M(+51.2%) | -$18.83M(-60.7%) | -$99.95M(+28.7%) |
| Sep 2023 | - | -$11.72M(+58.2%) | -$140.10M(+5.4%) |
| Jun 2023 | - | -$28.02M(+32.3%) | -$148.03M(+14.4%) |
| Mar 2023 | - | -$41.38M(+29.9%) | -$172.99M(+15.6%) |
| Dec 2022 | -$204.92M(+2.0%) | -$58.98M(-200.3%) | -$204.92M(+6.0%) |
| Sep 2022 | - | -$19.64M(+62.9%) | -$218.07M(+9.4%) |
| Jun 2022 | - | -$52.99M(+27.7%) | -$240.74M(-6.4%) |
| Mar 2022 | - | -$73.30M(-1.6%) | -$226.30M(-8.2%) |
| Dec 2021 | -$209.08M(+17.0%) | -$72.13M(-70.5%) | -$209.08M(-3.4%) |
| Sep 2021 | - | -$42.31M(-9.8%) | -$202.27M(+6.6%) |
| Jun 2021 | - | -$38.55M(+31.3%) | -$216.46M(+3.0%) |
| Mar 2021 | - | -$56.09M(+14.1%) | -$223.06M(+11.4%) |
| Dec 2020 | -$251.83M(+25.3%) | -$65.32M(-15.6%) | -$251.83M(+7.6%) |
| Sep 2020 | - | -$56.50M(-25.1%) | -$272.63M(+0.6%) |
| Jun 2020 | - | -$45.15M(+46.8%) | -$274.16M(+11.0%) |
| Mar 2020 | - | -$84.86M(+1.5%) | -$308.22M(+8.6%) |
| Dec 2019 | -$337.04M(-3.2%) | -$86.12M(-48.4%) | -$337.04M(-5.5%) |
| Sep 2019 | - | -$58.03M(+26.7%) | -$319.35M(+23.2%) |
| Jun 2019 | - | -$79.21M(+30.3%) | -$415.82M(-5.7%) |
| Mar 2019 | - | -$113.68M(-66.1%) | -$393.54M(-20.5%) |
| Dec 2018 | -$326.69M(+24.4%) | -$68.43M(+55.7%) | -$326.69M(-1.0%) |
| Sep 2018 | - | -$154.50M(-171.4%) | -$323.58M(+26.6%) |
| Jun 2018 | - | -$56.93M(-21.6%) | -$441.08M(-3.0%) |
| Mar 2018 | - | -$46.82M(+28.3%) | -$428.06M(+0.9%) |
| Dec 2017 | -$431.88M(-117.7%) | -$65.33M(+76.0%) | -$431.88M(-1.3%) |
| Sep 2017 | - | -$272.00M(-519.5%) | -$426.35M(-113.4%) |
| Jun 2017 | - | -$43.91M(+13.3%) | -$199.74M(+3.2%) |
| Mar 2017 | - | -$50.65M(+15.3%) | -$206.28M(-4.0%) |
| Dec 2016 | -$198.38M(-52.0%) | -$59.80M(-31.7%) | -$198.38M(-9.8%) |
| Sep 2016 | - | -$45.39M(+10.0%) | -$180.63M(-4.4%) |
| Jun 2016 | - | -$50.45M(-18.0%) | -$173.02M(-15.8%) |
| Mar 2016 | - | -$42.75M(-1.7%) | -$149.37M(-14.4%) |
| Dec 2015 | -$130.54M(-90.4%) | -$42.05M(-11.3%) | -$130.54M(-18.2%) |
| Sep 2015 | - | -$37.78M(-41.0%) | -$110.45M(-23.5%) |
| Jun 2015 | - | -$26.80M(-12.0%) | -$89.44M(-16.3%) |
| Mar 2015 | - | -$23.92M(-8.9%) | -$76.88M(-12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$68.56M(-8.6%) | -$21.95M(-30.9%) | -$68.56M(-10.0%) |
| Sep 2014 | - | -$16.77M(-17.8%) | -$62.33M(-3.6%) |
| Jun 2014 | - | -$14.24M(+8.6%) | -$60.14M(+1.8%) |
| Mar 2014 | - | -$15.59M(+0.9%) | -$61.24M(+2.9%) |
| Dec 2013 | -$63.10M(-21.5%) | -$15.73M(-7.9%) | -$63.10M(-4.1%) |
| Sep 2013 | - | -$14.58M(+4.9%) | -$60.62M(+2.7%) |
| Jun 2013 | - | -$15.34M(+12.1%) | -$62.31M(-10.7%) |
| Mar 2013 | - | -$17.45M(-31.7%) | -$56.30M(-8.4%) |
| Dec 2012 | -$51.94M(-8.5%) | -$13.25M(+18.6%) | -$51.94M(-1.9%) |
| Sep 2012 | - | -$16.27M(-74.4%) | -$50.96M(-14.7%) |
| Jun 2012 | - | -$9.33M(+28.8%) | -$44.41M(+6.9%) |
| Mar 2012 | - | -$13.09M(-6.8%) | -$47.69M(+0.4%) |
| Dec 2011 | -$47.89M(+14.2%) | -$12.26M(-26.1%) | -$47.89M(+7.5%) |
| Sep 2011 | - | -$9.73M(+22.8%) | -$51.80M(+9.7%) |
| Jun 2011 | - | -$12.60M(+5.3%) | -$57.36M(-2.4%) |
| Mar 2011 | - | -$13.30M(+17.7%) | -$56.02M(-0.4%) |
| Dec 2010 | -$55.81M(-787.5%) | -$16.17M(-5.7%) | -$55.81M(-750.2%) |
| Sep 2010 | - | -$15.29M(-35.8%) | -$6.57M(-42.1%) |
| Jun 2010 | - | -$11.26M(+14.0%) | -$4.62M(+33.5%) |
| Mar 2010 | - | -$13.09M(-139.6%) | -$6.94M(-10.3%) |
| Dec 2009 | -$6.29M(+83.9%) | $33.08M(+347.9%) | -$6.29M(+87.3%) |
| Sep 2009 | - | -$13.35M(+1.7%) | -$49.43M(-8.9%) |
| Jun 2009 | - | -$13.58M(-9.2%) | -$45.38M(-7.3%) |
| Mar 2009 | - | -$12.44M(-23.7%) | -$42.29M(-8.1%) |
| Dec 2008 | -$39.14M(+14.6%) | -$10.06M(-8.2%) | -$39.14M(+8.0%) |
| Sep 2008 | - | -$9.30M(+11.4%) | -$42.56M(+5.6%) |
| Jun 2008 | - | -$10.49M(-13.0%) | -$45.07M(-0.5%) |
| Mar 2008 | - | -$9.29M(+31.1%) | -$44.86M(+2.1%) |
| Dec 2007 | -$45.80M(+2.2%) | -$13.48M(-14.2%) | -$45.80M(-4.3%) |
| Sep 2007 | - | -$11.81M(-14.8%) | -$43.91M(-0.5%) |
| Jun 2007 | - | -$10.28M(-0.5%) | -$43.69M(+2.9%) |
| Mar 2007 | - | -$10.23M(+11.7%) | -$44.99M(+2.9%) |
| Dec 2006 | -$46.86M(-124.9%) | -$11.59M(-0.0%) | -$46.34M(-16.6%) |
| Sep 2006 | - | -$11.59M(0.0%) | -$39.75M(-19.9%) |
| Jun 2006 | - | -$11.59M(0.0%) | -$33.16M(-24.8%) |
| Mar 2006 | - | -$11.59M(-132.0%) | -$26.57M(-33.0%) |
| Dec 2005 | -$20.83M(-136.5%) | -$4.99M(0.0%) | -$19.97M(-33.3%) |
| Sep 2005 | - | -$4.99M(0.0%) | -$14.98M(-50.0%) |
| Jun 2005 | - | -$4.99M(0.0%) | -$9.99M(-100.0%) |
| Mar 2005 | - | -$4.99M | -$4.99M |
| Dec 2004 | -$8.81M(-33.4%) | - | - |
| Dec 2003 | -$6.60M | - | - |
FAQ
- What is Amicus Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual EBIT year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Amicus Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. TTM EBIT year-on-year change?
What is Amicus Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of FOLD is $20.84M
What is the all-time high annual EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual earnings before interest & taxes is $20.84M
What is Amicus Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, FOLD annual earnings before interest & taxes has changed by +$120.79M (+120.85%)
What is Amicus Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of FOLD is -$7.62M
What is the all-time high quarterly EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $33.08M
What is Amicus Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, FOLD quarterly earnings before interest & taxes has changed by -$20.24M (-160.35%)
What is Amicus Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of FOLD is $25.16M
What is the all-time high TTM EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $45.40M
What is Amicus Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, FOLD TTM earnings before interest & taxes has changed by +$74.24M (+151.27%)